Many of these are questions that remain unanswered in human research
MECHANISM CATEGORIES RESEARCH CONDITIONS SAFETY Side effects Limited human safety data Animal toxicology shows wide therapeutic window Injection-site reactions reported anecdotally Known interactions Anticoagulants (theoretical, due to angiogenic activity unstudied) Contraindications Active malignancy (theoretical, due to angiogenic mechanism) Pregnancy/lactation (unstudied) REGULATORY STATUS FDA Placed on FDA Category 2 of the 503A bulks list (September 2023 update), barring compounding pharmacies from preparing it under section 503A
By promoting faster healing and reducing redness, BPC 157 may help improve the overall appearance of acne-prone skin
We have to consider that stimulating a given nucleus might not only result in a specific outcome because of its circuit connectivity, but also because each nucleus could have a very different composition of glutamatergic, GABAergic, and glycinergic neurons
Many of these novel therapeutic agents are already being tested in clinical trials and they may 1 day reshape the landscape of SLE treatment
PMID 28254655 Sikiric P, Seiwerth S, et al